Abstract
Purpose
This study aimed to establish the prevalence, severity, and correlates of psychological distress and impaired generic health-related quality of life (HRQOL) in testicular cancer (TC) survivors.
Methods
Men who had completed active anti-cancer treatment for TC between 6 months and 5 years previously showing no evidence of recurrence were recruited from 14 Australian cancer centers from September 2009 to February 2011. Participants completed a self-report questionnaire measuring demographic, disease, and treatment information, psychological distress (i.e., depression, anxiety, and stress; DASS21), generic health-related quality of life (HRQOL; SF-36v2), TC-specific HRQOL (EORTC QLQ-TC26), coping (MAC), social support (DUFSS), and unmet needs (CaSUN).
Results
Of 486 eligible TC survivors, 244 (50.2 %) completed the questionnaire. Compared with normative data, TC survivors reported: small but statistically significant increases in mean levels of anxiety and depression; a greater prevalence of moderate to extremely severe anxiety (19 %) and depression (20 %); and significant deficits to mostly mental aspects of generic HRQOL. The most problematic TC-specific HRQOL issues (e.g., fear of recurrence) were also more mental than physical. In multiple regression analyses, the strongest correlates of psychological distress and impaired generic HRQOL were psychosocial (e.g., helpless/hopeless coping and lower social support) rather than disease or treatment factors.
Conclusions
Generally, TC survivors appear to experience mild psychological distress and HRQOL impairments, while a vulnerable subgroup experience more severe morbidity.
Implications for Cancer Survivors
There is a need to identify TC survivors at risk of poorer outcomes and for interventions to target the areas of greatest impairment (i.e., psychological distress and mental HRQOL).
Similar content being viewed by others
References
Cancer Incidence in Five Continents. Lyon: IARC. 2007.
Haugnes HS, Bosl GJ, Boer H, et al. Long-term and late effects of germ cell testicular cancer treatment and implications for follow-up. J Clin Oncol. 2012;30:3752–63.
Fleer J, Hoekstra HJ, Sleijfer DT, et al. Quality of life of testicular cancer survivors and the relationship with sociodemographics, cancer-related variables, and life events. Support Care Cancer. 2006;14:251–9.
Kim C, McGlynn KA, McCorkle R, et al. Quality of life among testicular cancer survivors: a case-control study in the United States. Qual Life Res: Int J Qual Life Asp Treat Care Rehabil. 2011;20:1629–37.
Joly F, Heron JF, Kalusinski L, et al. Quality of life in long-term survivors of testicular cancer: a population-based case-control study. J Clin Oncol. 2002;20:73–80.
Gudbergsson SB, Fosså SD, Dahl AA. Are there sex differences in the work ability of cancer survivors? Norwegian experiences from the NOCWO study. Support Care Cancer. 2011;19:323–31.
Rossen PB, Pedersen AF, Zachariae R, et al. Health-related quality of life in long-term survivors of testicular cancer. J Clin Oncol. 2009;27:5993–9.
Pedersen AD, Rossen P, Mehlsen MY, et al. Long-term cognitive function following chemotherapy in patients with testicular cancer. J Int Neuropsychol Soc. 2009;15:296–301.
Dahl AA, Haaland CF, Mykletun A, et al. Study of anxiety disorder and depression in long-term survivors of testicular cancer. J Clin Oncol. 2005;23:2389–95.
Skoogh J, Steineck G, Stierner U, et al. Testicular-cancer survivors experience compromised language following chemotherapy: findings in a Swedish population-based study 3-26 years after treatment. Acta Oncol. 2012;51:185–97.
Fossa SD, Dahl AA, Loge JH. Fatigue, anxiety, and depression in long-term survivors of testicular cancer. J Clin Oncol. 2003;21:1249–54.
Mykletun A, Dahl AA, Haaland CF, et al. Side effects and cancer-related stress determine quality of life in long-term survivors of testicular cancer. J Clin Oncol. 2005;23:3061–8.
Wilson IB, Cleary PD. Linking clinical variables with health-related quality of life: a conceptual model of patient outcomes. J Am Med Assoc. 1995;273:59–65.
Smith AB, King M, Butow P, Grimison P, Olver I. Reduced quality of life in internet-panel controls. Epidemiology. 2013;24:462–3.
Smith AB, King M, Butow P, Olver I. A comparison of data quality and practicality of online versus postal questionnaires in a sample of testicular cancer survivors. Psychooncology. 2013;22:233–7.
Smith A, King M, Butow P, et al. The prevalence and correlates of supportive care needs in testicular cancer survivors: a cross-sectional study. Psychooncology. 2013;22:2557–64.
Lovibond SH, Lovibond PF. Manual for the depression anxiety stress scales. Secondth ed. Sydney: Psychology Foundation; 1995.
Ware Jr JE, Kosinski M, Bjorner JB, Turner-Bowker DM, Gandek B, Maruish ME. User’s manual for the SF-36v2 Health Survey. 2nd ed. Lincoln: Quality Metric Incorporated; 2007.
Holzner B, Efficace F, Basso U, et al. Cross-cultural development of an EORTC questionnaire to assess health-related quality of life in patients with testicular cancer: the EORTC QLQ-TC26. Qual Life Res. 2013;22:369–78.
Watson M, Greer S, Young J, Inayat Q, Burgess C, Robertson B. Development of a questionnaire measure of adjustment to cancer: the MAC scale. Psychol Med. 1988;18:203–9.
Broadhead WE, Gehlbach SH, de Gruy FV, Kaplan BH. The Duke-UNC Functional Social Support Questionnaire. Measurement of social support in family medicine patients. Med Care. 1988;26:709–23.
Hodgkinson K, Butow P, Hunt GE, et al. The development and evaluation of a measure to assess cancer survivors’ unmet supportive care needs: the CaSUN (Cancer Survivors’ Unmet Needs measure). Psychooncology. 2007;16:796–804.
Fayers PM, Curran D, Machin D. Incomplete quality of life data in randomized trials: missing items. Stat Med. 1998;17:679–96.
Hawthorne G, Osborne RH, Taylor A, Sansoni J. The SF36 Version 2: critical analyses of population weights, scoring algorithms and population norms. Qual Life Res. 2007;16:661–73.
Kutner MH, Nachtsheim C, Neter J. Applied linear regression models. McGraw-Hill/Irwin; 2004.
AIHW. Cancer in Australia 2010: an overview. In: Cancer series. AIHW, Canberra. 2010. http://www.aihw.gov.au/publication-detail/?id=6442472459. Accessed 8 March 2013 2013.
Kessler RC, Wai TC, Demler O, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:617–27.
Cohen J. A power primer. Psychol Bull. 1992;112:155–9.
Fossa SD, Dahl AA. Short Form 36 and Hospital Anxiety and Depression Scale: a comparison based on patients with testicular cancer. J Psychosom Res. 2002;52:79–87.
Rutskij R, Gaarden T, Bremnes R, et al. A study of coping in long-term testicular cancer survivors. Psychol Health Med. 2010;15:146–58.
Johansson M, Rydén A, Finizia C. Mental adjustment to cancer and its relation to anxiety, depression, HRQL and survival in patients with laryngeal cancer—a longitudinal study. BMC Cancer. 2011;11.
Simard S, Thewes B, Humphris G, et al. Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies. J Cancer Surviv. 2013;1–23.
Paterson C, Jones M, Rattray J, Lauder W. Exploring the relationship between coping, social support and health-related quality of life for prostate cancer survivors: a review of the literature. Eur J Oncol Nurs. 2013;17:750–9.
Jonker-Pool G, Van de Wiel HB, Hoekstra HJ, et al. Sexual functioning after treatment for testicular cancer—review and meta-analysis of 36 empirical studies between 1975-2000. Arch Sex Behav. 2001;30:55–74.
Steiner JF, Cavender TA, Nowels CT, et al. The impact of physical and psychosocial factors on work characteristics after cancer. Psychooncology. 2008;17:138–47.
Pedersen AF, Rossen P, Olesen F, Von Der Maase H, Vedsted P. Fear of recurrence and causal attributions in long-term survivors of testicular cancer. Psychooncology. 2012;21:1222–8.
Skaali T, Fossa SD, Bremnes R, et al. Fear of recurrence in long-term testicular cancer survivors. Psycho-Oncology. 2009;18:580–8.
Lewis FM. The impact of cancer on the family: a critical analysis of the research literature. Patient Educ Couns. 1986;8:269–89.
Fegg MJ, Gerl A, Vollmer TC, et al. Subjective quality of life and sexual functioning after germ-cell tumour therapy. Br J Cancer. 2003;89:2202–6.
Kim C, McGlynn KA, McCorkle R, et al. Fertility among testicular cancer survivors: a case-control study in the US. J Cancer Survivorship. 2010;4:266–73.
Greer S, Moorey S, Baruch JDR, et al. Adjuvant psychological therapy for patients with cancer: a prospective randomised trial. Br Med J. 1992;304:675–80.
Gottlied BH, Wachala ED. Cancer support groups: a critical review of empirical studies. Psychooncology. 2007;16:379–400.
Rosenberg JP. Circles in the surf: Australian masculinity, mortality and grief. Crit Public Health. 2009;19:417–26.
Griffiths KM, Farrer L, Christensen H. The efficacy of internet interventions for depression and anxiety disorders: a review of randomised controlled trials. Med J Aust. 2010;192:S4–11.
Acknowledgments
This study was co-funded by beyondblue and Cancer Australia (grant number 507961). Dr Allan “Ben” Smith was supported by an Australian Rotary Health Ian Scott Scholarship. Professor Butow holds a NHMRC Senior Principal Research Fellowship, and Professor King is supported by the Australian Government through Cancer Australia. The study was conducted by PoCoG in collaboration with ANZUP. The authors would like to thank all the men who participated in the study, as well as investigators and trials staff at the following hospitals: Border Medical Oncology, Canberra, Concord Repatriation General, Flinders Medical Centre, Liverpool, Princess Alexandra, Peter MacCallum Cancer Centre, Prince of Wales, Royal Adelaide, Royal North Shore, Royal Prince Alfred, St George, Tweed and Westmead.
Conflicts of interest
The authors declare that they have no competing interests.
Informed consent
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000 (5). Informed consent was obtained from all patients for being included in the study.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
ESM 1
(DOCX 155 kb)
Rights and permissions
About this article
Cite this article
Smith, A.“., Butow, P., Olver, I. et al. The prevalence, severity, and correlates of psychological distress and impaired health-related quality of life following treatment for testicular cancer: a survivorship study. J Cancer Surviv 10, 223–233 (2016). https://doi.org/10.1007/s11764-015-0468-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11764-015-0468-5